Virtual Medicinal Product (VMP) - Generic Migraleve Pink tablets

Name Details

Name Start Date End Date
Name Current Name Generic Migraleve Pink tablets Start Date 21-12-2002 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Never Valid To Prescribe As A VMP
Controlled Drug Category
Schedule 5 (CD Inv)
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
Other

Codes

ATC Code
N02BE51
BNF Start Date End Date
Current BNF 04070401 Start Date 04-04-2022 End Date
Previous BNF 04070401 Start Date 22-02-2005 End Date 03-04-2022
Previous BNF 04070100 Start Date 18-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
3546911000001102 21-12-2002

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Buclizine hydrochloride Based on Ingredient Substance 6.25 mg
Codeine phosphate Based on Ingredient Substance 8 mg
Paracetamol Based on Ingredient Substance 500 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
8 tablet
12 tablet
16 tablet
24 tablet
32 tablet
48 tablet